Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales
Biotechnology Journal - Germany
doi 10.1002/biot.201700665
Full Text
Open PDFAbstract
Available in full text
Date
February 9, 2018
Authors
Publisher
Wiley